WAREHAM JOHN P 4
4 · RESMED INC · Filed May 28, 2019
Insider Transaction Report
Form 4
RESMED INCRMD
WAREHAM JOHN P
Director
Transactions
- Sale
ResMed Common Stock
2019-05-24$114.00/sh−23,629$2,693,706→ 13,000 total - Exercise/Conversion
ResMed Common Stock
2019-05-24$51.25/sh+9,628$493,435→ 22,628 total - Sale
ResMed Common Stock
2019-05-24$113.44/sh−11,085$1,257,427→ 13,000 total - Exercise/Conversion
ResMed Common Stock
2019-05-24$52.02/sh+23,629$1,229,181→ 36,629 total - Exercise/Conversion
ResMed Common Stock Options
2019-05-24−9,628→ 0 totalExercise: $51.25From: 2016-11-11Exp: 2020-11-13→ ResMed Common Stock (9,628 underlying) - Exercise/Conversion
ResMed Common Stock Options
2019-05-24−23,629→ 0 totalExercise: $52.02From: 2015-11-11Exp: 2021-11-19→ ResMed Commmon Stock (23,629 underlying) - Exercise/Conversion
ResMed Common Stock
2019-05-24$51.25/sh+11,085$568,106→ 24,085 total - Sale
ResMed Common Stock
2019-05-24$114.00/sh−9,628$1,097,592→ 13,000 total - Exercise/Conversion
ResMed Common Stock Options
2019-05-24−11,085→ 9,628 totalExercise: $51.25From: 2016-11-11Exp: 2020-11-13→ ResMed Common Stock (11,085 underlying)
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $113.44 to $113.45. The price reported above reflects the weighted average sale price.
- [F2]Represents date options first became exercisable. Options vest on the earlier of (i) the first November 11 following the Grant Date, or (ii) the date of the first (1st) annual meeting of stockholders of the Company following the Grant Date.